Literature DB >> 10763093

Evidence-based medicine in the treatment of non-small-cell lung cancer.

M S Reif1, M A Socinski, M P Rivera.   

Abstract

Treatment decisions for non-small-cell lung cancer require accurate initial staging of patients. Typically surgical resection is recommended for early stage disease, while chemotherapy in conjunction with radiotherapy and possibly surgical resection is recommended for selected patients with locally advanced disease. Chemotherapy clearly has been demonstrated to improve survival and quality of life in metastatic disease. Surgical, chemotherapeutic, and radiotherapy treatment options as well as the role of multi-modality therapy will be discussed focusing on the evidence for various stages of non-small-cell lung cancer.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10763093     DOI: 10.1016/s0272-5231(05)70011-3

Source DB:  PubMed          Journal:  Clin Chest Med        ISSN: 0272-5231            Impact factor:   2.878


  17 in total

1.  Compromised video-assisted thoracoscopic segmental resection for high-risk patients with stage I lung cancer near the lung hilum.

Authors:  Shunsuke Yamada; Haruka Takeichi; Hiroshi Inoue
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2006-09

Review 2.  Surgery for non-small cell lung cancer: systematic review and meta-analysis of randomised controlled trials.

Authors:  G Wright; R L Manser; G Byrnes; D Hart; D A Campbell
Journal:  Thorax       Date:  2006-01-31       Impact factor: 9.139

3.  Effect of lung cancer surgery on quality of life.

Authors:  T Win; L Sharples; F C Wells; A J Ritchie; H Munday; C M Laroche
Journal:  Thorax       Date:  2005-03       Impact factor: 9.139

4.  Pleural lavage cytology predicts recurrence and survival, even in early non-small cell lung cancer.

Authors:  Federico Mazza; Enrico Ferrari; Paola Maineri; Beatrice Dozin; Giovanni Battista Ratto
Journal:  Surg Today       Date:  2014-05-10       Impact factor: 2.549

5.  Six minute walking test and carbon monoxide diffusing capacity for non-small cell lung cancer: easy performed tests in every day practice.

Authors:  Paul Zarogoulidis; Theodora Kerenidi; Haidong Huang; Theodoros Kontakiotis; Ourania Tremma; Konstantinos Porpodis; Anastasios Kalianos; Ageliki Rapti; Christoforos Foroulis; Athanasios Zissimopoulos; Nikolaos Courcoutsakis; Konstantinos Zarogoulidis
Journal:  J Thorac Dis       Date:  2012-12       Impact factor: 2.895

6.  18F-FDG PET during stereotactic body radiotherapy for stage I lung tumours cannot predict outcome: a pilot study.

Authors:  Erwin M Wiegman; Jan Pruim; Jan F Ubbels; Harry J M Groen; Johannes A Langendijk; Joachim Widder
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-01-06       Impact factor: 9.236

7.  A prediction model for lymph node metastases using pathologic features in patients intraoperatively diagnosed as stage I non-small cell lung cancer.

Authors:  Fei Zhao; Yue Zhou; Peng-Fei Ge; Chen-Jun Huang; Yue Yu; Jun Li; Yun-Gang Sun; Yang-Chun Meng; Jian-Xia Xu; Ting Jiang; Zhi-Xuan Zhang; Jin-Peng Sun; Wei Wang
Journal:  BMC Cancer       Date:  2017-04-13       Impact factor: 4.430

8.  Survival from lung cancer in England and Wales up to 2001.

Authors:  Y K Zee; T Eisen
Journal:  Br J Cancer       Date:  2008-09-23       Impact factor: 7.640

Review 9.  Surgical treatment of early-stage non-small-cell lung cancer.

Authors:  Paul E Van Schil; Bram Balduyck; Michèle De Waele; Jeroen M Hendriks; Marjan Hertoghs; Patrick Lauwers
Journal:  EJC Suppl       Date:  2013-09

Review 10.  Novel teatment options in early-stage non-small-cell lung cancer.

Authors:  Jan P van Meerbeeck
Journal:  EJC Suppl       Date:  2013-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.